Kintsugi ceases commercial operations and releases its voice AI for mental health diagnosis as open source, citing FDA regulatory hurdles.…
10% eGFR improvement in diabetic kidney disease highlights senolytic therapy potential
Senolytic therapies, such as dasatinib plus quercetin, show promise in diabetic kidney disease by targeting cellular senescence. Clinical trials report…
Mass General Brigham AI tool reveals 40% clinical trial enrollment boost with no bias
Mass General Brigham’s AIwithCare uses generative AI to screen EHRs for trial eligibility, increasing enrollment by 40% without racial or…
Unregulated AI Therapy Bots Pose Significant Risks as Demand Soars
New research shows 40% of mental health chatbots give dangerous advice, prompting APA warnings and FDA scrutiny of the rapidly…
Vision transformers revolutionize brain metastasis prognosis amid regulatory challenges
Vision Transformers achieve 92% accuracy in predicting radiotherapy outcomes for brain metastasis, surpassing CNNs by 8%. While promising personalized treatment…
AI-Powered ECG Wearables Reshape Cardiac Monitoring as Regulatory and Liability Challenges Emerge
The integration of AI diagnostics in wearable ECG devices demonstrates 92% arrhythmia detection accuracy while facing complex FDA oversight and…